Kolon Life Science kolonls.co.kr


Kolon Life Science develops cell and gene therapies including Invossa, a cell-mediated gene therapy for osteoarthritis. The company is also engaged in the business of providing active pharmaceuticals ingredients, eco-chemicals including antimicrobials for personal care and industrial applications, as well as water treatment solutions.

Kolon Life Science develops cell and gene therapies including Invossa, a cell-mediated gene therapy for osteoarthritis. The company is also engaged in the business of providing active pharmaceuticals ingredients, eco-chemicals including antimicrobial...Show all

Company (Alive / Active)

Phone:

Fax:




South Korea

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Kolon Life Science $0M Dec 29, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Kolon Life Science Jobs

jobs by Indeed job search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pharmaceutical composition for preventing or treating osteoarthritis Jun 29, 2018 Application
Method for assessing validity of cell therapy product Jun 29, 2018 Application